Literature DB >> 7952878

Heterogeneity of alpha 1-adrenoceptor subtypes involved in adrenergic contractions of dog blood vessels.

Y Kohno1, H Saito, M Takita, S Kigoshi, I Muramatsu.   

Abstract

1. We determined the alpha 1-adrenoceptor subtypes involved in adrenergic contractions of eight different blood vessels isolated from the dog. 2. Noradrenaline produced concentration-dependent contractions in all the blood vessels tested, which were competitively inhibited by prazosin, WB4101, HV723 and 5-methylurapidil. However, there was considerable difference between the vessels with regard to the pKB values for all the antagonists. The alpha 1-adrenoceptors of dog vertebral and carotid arteries had high affinity for prazosin (pKB > 9.0) but low affinity for WB4101 (< 8.5), 5-methylurapidil (< 7.5) and HV723 (< or = 8.5). By contrast, HV723 had higher affinity (> 9.0) than prazosin (< 8.3), WB4101 (< 8.7) and 5-methylurapidil (< 8.2) in the portal vein, mesenteric artery and vein, and renal artery. In the femoral artery and vein, however, the four antagonists showed pKB values in the range 8.0-8.7. 3. Chloroethylclonidine (10 microM) produced a remarkable reduction of the contractile responses to noradrenaline in the vertebral and carotid arteries as compared with those in the other vessels. Nifedipine inhibited the responses to noradrenaline in all the tissues tested, and had marked effects in the portal vein. 4. Sympathetic adrenergic contractions induced by transmural electrical stimulation were also inhibited by prazosin and HV723 at different potencies among tissues. The relative potencies of both the antagonists paralleled the relationship in inhibiting the responses to exogenous noradrenaline in each vessel. 5. According to recent alpha l-adrenoceptor subclassification, the present results suggest that the contractions of blood vessels induced by endogenous and exogenous noradrenaline are mediated through different alpha l-adrenoceptor subtypes heterogeneously distributed in each vessel; presumably, the alpha 1 B subtype in the carotid and vertebral arteries, the alpha IN subtype in the visceral region and the alpha IL subtype in the femoral region. Regionally different expression of alpha 1-adrenoceptor subtypes may be in part associated with the regional heterogeneity of sympathetic responses in the blood vessels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7952878      PMCID: PMC1910263          DOI: 10.1111/j.1476-5381.1994.tb13206.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA.

Authors:  D M Perez; M T Piascik; R M Graham
Journal:  Mol Pharmacol       Date:  1991-12       Impact factor: 4.436

Review 2.  Molecular biology of alpha-adrenergic receptors: implications for receptor classification and for structure-function relationships.

Authors:  J W Lomasney; S Cotecchia; R J Lefkowitz; M G Caron
Journal:  Biochim Biophys Acta       Date:  1991-10-26

3.  Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype.

Authors:  D A Schwinn; J W Lomasney; W Lorenz; P J Szklut; R T Fremeau; T L Yang-Feng; M G Caron; R J Lefkowitz; S Cotecchia
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

4.  Sequence of a rat brain cDNA encoding an alpha-1B adrenergic receptor.

Authors:  M M Voigt; J Kispert; H M Chin
Journal:  Nucleic Acids Res       Date:  1990-02-25       Impact factor: 16.971

Review 5.  The pharmacology of alpha 1- and alpha 2-adrenoceptors: evidence for and against a further subdivision.

Authors:  J R Docherty
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

Review 6.  Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+.

Authors:  K P Minneman
Journal:  Pharmacol Rev       Date:  1988-06       Impact factor: 25.468

7.  Relation between adrenergic neurogenic contraction and alpha 1-adrenoceptor subtypes in dog mesenteric and carotid arteries and rabbit carotid arteries.

Authors:  I Muramatsu
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

8.  Comparison between sympathetic adrenergic and purinergic transmission in the dog mesenteric artery.

Authors:  I Muramatsu; T Ohmura; M Oshita
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

9.  A regional difference in alpha 1-adrenoceptors in canine arteries.

Authors:  I Takayanagi; K Koike; K Kawano; S Onozuka
Journal:  Arch Int Pharmacodyn Ther       Date:  1988 Jul-Aug

10.  Pharmacological subclassification of alpha 1-adrenoceptors in vascular smooth muscle.

Authors:  I Muramatsu; T Ohmura; S Kigoshi; S Hashimoto; M Oshita
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

View more
  5 in total

1.  Discrimination by SZL49 between contractions evoked by noradrenaline in longitudinal and circular muscle of human vas deferens.

Authors:  Nnaemeka I B Amobi; John Guillebaud; A V Kaisary; Eileen Turner; I Christopher H Smith
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

2.  Insights into the functional roles of alpha(1)-adrenoceptor subtypes in mouse carotid arteries using knockout mice.

Authors:  Clare Deighan; Laura Methven; Mustafa M Naghadeh; Alexis Wokoma; Joyce Macmillan; Craig J Daly; Akito Tanoue; Gozoh Tsujimoto; John C McGrath
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

3.  Pharmacological profiles of a novel alpha 1-adrenoceptor agonist, PNO-49B, at alpha 1-adrenoceptor subtypes.

Authors:  I Muramatsu; T Ohmura; S Kigoshi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

4.  Heterogeneity of neurogenic responses in intra- and extrameningeal arteries of dogs.

Authors:  Y Kohno; T Saito; H Saito; H Aoyama; Y Nojyo; S Kigoshi; I Muramatsu
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

5.  Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.

Authors:  D R Blue; D W Bonhaus; A P Ford; J R Pfister; N A Sharif; I A Shieh; R L Vimont; T J Williams; D E Clarke
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.